Korean Hereditary Breast Cancer Study
Conditions
Breast Cancer - Ovarian Cancer
Conditions: official terms
Breast Neoplasms
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
1. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer.

2. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer.

3. To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation.

4. To evaluate the prevalence of ovarian cancer of population of above 3 groups.
Detailed Description
1. To find founder mutation in Korean

2. To correlation prevalence with risk evaluation

3. To find risk factors concerning life style
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: N/A
Minimum Age: 20 Years
Gender: Both
Criteria: Inclusion Criteria:

- Over 19 years old

- Agree to this study

- Breast cancer patient with family history of breast/ovarian cancer (1 subgroup)

- Breast cancer patient; young age (<40), bilateral, male, combined ovarian (2 subgroup)

- Family members with 1, 2 subgroups (3 subgroup)

Exclusion Criteria:

- Under 20 years old

- Unable to decide for oneself
Location
Department of Surgery, Breast & Endocrine Service Seoul National University Bundang Hospital
Seongnam-Si, Gyeonggi-do, Korea, Republic of
Status: Recruiting
Contact: Sung-Won Kim, M.D.,Ph.D. - 82-31-787-7094 - brca@korea.com
Start Date
November 2007
Completion Date
May 2017
Sponsors
Korean Breast Cancer Study Group
Source
Korean Breast Cancer Study Group
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page